Inflammatory acne, red papules, pustules and nodules that can scar, is treated in 2026 with proven prescription combinations. Guidelines tighten antibiotic use, define isotretinoin candidates, and one prescription combination moved over the counter. Excess sebum, follicular plugging, Cutibacterium acnes growth and inflammation drive these lesions from the microcomedone stage, according to the SkinTherapyLetter review SkinTherapyLetter review. That early start explains why painful spots need steady treatment, not spot treatment alone.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why these breakouts turn red and scar
- Which prescriptions do guidelines favor?
- What is new over the counter?
- Which options lack strong support?
Why these breakouts turn red and scar
A plugged follicle traps oil and skin cells. Bacteria multiply inside the plug. The immune response brings redness, swelling, pus and pain.
Papules stay solid and tender. Pustules contain visible pus. Nodules sit deeper, hurt more, and carry higher scarring risk. Early inflammation means picking or delay can leave lasting marks.
Which prescriptions do guidelines favor?
The American Academy of Dermatology strongly recommends benzoyl peroxide, topical retinoids, fixed-combination topical antibiotics, and oral doxycycline for acne vulgaris in patients 9 years and older, described in the Dermatology Times report on the AAD guideline Dermatology Times report on the AAD guideline. Retinoids include adapalene, tretinoin, tazarotene and trifarotene.
Good practice is to combine methods rather than use one product alone: Isotretinoin is reserved for severe acne, acne that scars, acne with major distress, or acne that fails standard topical or oral treatment. Use requires federal iPLEDGE pregnancy prevention. The 2026 EuroGuiDerm update EuroGuiDerm update also supports systemic isotretinoin for severe papulopustular, moderate nodular and severe nodular or conglobate acne.
- combine topical agents with different actions
- pair every oral antibiotic with benzoyl peroxide plus another topical
- keep systemic antibiotic courses limited in length
- consider a corticosteroid injection for a larger lesion
What is new over the counter?
The FDA approved adapalene 0.1% plus benzoyl peroxide 2.5% gel for over-the-counter use in ages 12 and older, according to the Patient Care report on the FDA decision Patient Care report on the FDA decision. The product had more than 15 years of prescription use.
Phase 3 trials found the fixed combination reduced inflammatory, noninflammatory and total lesions more than either ingredient alone or vehicle. More users reached clear or almost clear. Some response appeared by week 1, with local irritation as the main risk.
Which options lack strong support?
Chemical peels, laser and light devices, microneedling, dietary changes, vitamins and plant products had insufficient evidence in the AAD review. Microbiome and fatty-acid approaches still need larger replicated trials with standard endpoints. That gap matters for shoppers.
A device or supplement may feel gentler, but proof for red, deep lesions is thin. For persistent nodules, scarring, or failed treatment, prescription assessment comes before add-ons. Limited antibiotic courses with topical cotherapy remain the tested path, generally about three months in European guidance.